Pediatric physician-scientist interested in clinical and translational research and drug development innovation in Cystic Fibrosis and Pancreatic/GI diseases
Gastrointestinal care (incl. bowel screening): CF Trust is supporting a dedicated GI working group looking at access to GI experts and care &bowel screening, for PWCF. If you are familiar with local GI provision could complete our GI survey: https://t.co/VyrsaFDmgK
@CFRI_CureCF I am grateful for having worked with Carol as both a trainee and a colleague. Her impact on medicine and her patients will be enduring. Thank you.
Exciting study! Organoid models reveal a novel role for human tuft cells in gut regeneration upon damage. Video: Tuft cell division is triggered by IL-4, visualized in human gut AVIL-Clover reporter organoids (Credit: Daniel Krueger) https://t.co/gXhem2rw0B
Looking for PhD students/postdocs for my newly opened lab at the Institute of Human Biology of #Roche in Basel. We work on human lung, liver and gut #organoids. Send email + CV + motivation letter to [email protected] with header #IHB https://t.co/5Ki03fy4NH
📢 We’re THRILLED to launch CF Clinical Trial Connect (CTC), linking people with #cysticfibrosis who don’t benefit from CFTR modulators to clinical trials. 💫
Together, we’re working for a future where everyone with CF has a treatment. 💜
🔗 Learn more: https://t.co/3NcRcOqTgo
To our amazing Mission: Cure community — please join us on October 10th at 8:15 PM EST for our annual Moments of Hope Gala! This event is virtual, free to attend, and supports our continued fight against pancreatitis. 💙
Register Today: https://t.co/APfs2DswpD
Registration is open! The 2024 California Society of Physiologists 3rd Annual Meeting—an engaging day of physiology presentations, discussions, and networking opportunities! Keynote speaker: Tatum Simonson, Ph.D, UCSD @APSPhysiology@UCDavisMed—Register→ https://t.co/YIFxfbWyRn
Despite well documented benefits of improved pulmonary outcomes with ETI, the potential broad impact of ETI on gastrointestinal health remains unclear. More work by @AlanRSmyth et al to help shed light on this. @JournalofCF
Apologies for a dodgy link to our paper - DOI not yet up and running! This one works!
https://t.co/Xu9AjIuiFf
As a bonus, a really cool infographic depicting all of the MRI outcomes we measured with elexacaftor/tezacaftor/ivacaftor (ETI) in people with CF.
An enteric start to HLA-B27-associated autoimmune disease? https://t.co/TyE7kuaxkg
Work from @drmapaley, @XinboYang777 et al. suggests early antigen exposure in gut leads to pathogenic CD8+ T cell development in axial spondyloarthritis & acute anterior uveitis.
@WUSTLmed
@ebburgenerMD@Momademia Since food came before oxygen I am thinking he has a future in gastroenterology. Even better, a CF gastroenterologist to combine food and oxygen! 😄
Upcoming Webinar Thurs 8/8/24 - Demystifying the Colonoscopy Process!
Join Jeffrey King, MD, Gastroenterologist, for a candid conversation about how to prepare for a successful colonoscopy with CF, and what to expect during the procedure.
Register: https://t.co/j7V2Y79gey
A surprising benefit of inflammation.
Study from Tayyab Rehman et al. may shift thinking about suppressing inflammation in patients with Cystic Fibrosis treated with CFTR modulators. https://t.co/sQ0FSbvnRG